<p>Prompted by reoccurring
statements found in the literature, at seminars, and at conferences, regarding
the perceived inferiority of
“easy-to-make” compounds compared to molecules obtained through other
reaction schemes, we have investigated if there are significant differences between
these two groups of compounds. As a surrogate for the “easy-to-make” set, we
compiled screening compounds made from the most popular chemical reaction in
medicinal chemistry, amide bond formation. The other set contained screening
compounds made by any other coupling reaction using the expert system for named
reaction identification and classification (namerxn) from NextMove Scientific
Software. The data sets were rigorously compiled from the AstraZeneca
electronic notebooks and screening databases. We can conclude that novelty,
diversity and molecular complexity is nowadays not compromised by the use of
amide bond formation, mainly due to a steady increase of unique amines made
available during the last decades. With this, we can demonstrate that “easy”
chemistry allows speedy access to a broad chemical space, facilitating progress
in medicinal chemistry projects, and opens the possibility of synthesis
automation and new technologies like DNA encoded libraries. That said, we also
stress that innovative chemistry must be continuously developed to maintain the
production of new elaborate building blocks enabling fast advancement in
medicinal chemistry and drug design. </p>